Views & Analysis | Perspectives on pharma industry issues

R&D

Inspection readiness is now a commercial question

Manufacturers of advanced therapies are discovering that a digital quality system does more than satisfy inspectors.

Digital

Abstract AI concept, turquoise hexagonals on dark background

Sponsored

The hardest part of becoming an AI-first company: It’s not t...

Axtria president and CEO Jaswinder Chadha on the culture and governance decisions behind his company’s AI transformation.

R&D

A certificate of analysis should be evidence, not a sales do...

Regulators weighing peptide bulk substances can ask whether today's documentation rules fit the risks of this supply chain.

R&D

From phase 1 to phase 3: Scaling radiopharmaceutical trials

Success in radiopharmaceutical development depends on creating and maintaining an integrated, scalable system.

Patients

pharmaphorum podcast Episode 285, Donna Cryer, CryerHealth, LLC

Patients not just at the table, but creating their own: In c...

Donna Cryer, founding partner and Chief Patient Officer of CryerHealth, LLC discusses why is patient inclusion is not the same as patient leadership.

Articles

Editor’s voice – July 2011

Rebecca Aris discloses what’s been going on behind the scenes at pharmaphorum lately and shows what we can expect in the coming month! Unsurprisingly it’s been another busy month on pharmaphorum with more great content pouring onto the site...

Articles

Paediatrics: an unexplored and rewarding population – the ri...

As outcomes research becomes increasingly understood, and given the associated incentives could it be time to explore healthcare interventions in children? Linda Abetz-Webb explores... Many treatments with potential value in children have not been tested in paediatric populations. Incentives and penalties to encourage...

Articles

Social media and corporate influence: the case for a thought...

In a world where decisions are more likely to be made on the basis of a recommendation can pharma really influence what is being said about its brands in the social media space? What currently appears to be on the senior corporate executive mind is the question: “How can we, as a corporation, influence the social media debate about...

Sales & Marketing

Sponsored

Solution Spotlight: BrandPRO Biopharma

Strong strategy on paper can unravel when priorities collide. BrandPRO Biopharma gives pharmaceutical teams a place to put their decisions to the test

Sales & Marketing

Benefits of marketing with AI tools, upward trajectory graph

Ending rational disengagement: Bridging the strategy-reality...

Organisations must secure strategic buy-in, embed platforms in existing workflows, and provide reps with actionable physician-ready hypotheses.

Digital

Sponsored

The hardest part of becoming an AI-first company: It’s not t...

Axtria president and CEO Jaswinder Chadha on the culture and governance decisions behind his company’s AI transformation.

Digital

Sponsored

Antiviral development in the age of AI: From pre-IND to earl...

hVIVO experts discuss how advancements in AI and machine learning are pushing industry beyond the bounds of a traditional "one virus, one drug" model.